These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 3985644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Complex evaluation of the effect of some cytostatic hexitol derivatives.
    Holczinger L, Somfai-Relle S, Institoris E, Gáti E, Turi G.
    Oncology; 1980; 37 Suppl 1():104-8. PubMed ID: 7454197
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hungarian anticancer drugs (antineoplastics).
    Kerpel-Fronius S.
    Ther Hung; 1982; 30(3):110-21. PubMed ID: 6095482
    [No Abstract] [Full Text] [Related]

  • 6. Dianhydrogalactitol and neural tumors: an in vitro, in vivo preclinical evaluation.
    Helson L, Rozsa P, Hajdu E, Helson JL.
    Cancer Treat Rep; 1980; 64(12):1287-94. PubMed ID: 7471118
    [Abstract] [Full Text] [Related]

  • 7. Phase II trial of dianhydrogalactitol in the treatment of children with refractory childhood malignancies: a report from the Children's Cancer Study Group.
    Finklestein JZ, Shore N, Krivit W, Hammond D, Higgins G.
    Cancer Treat Rep; 1985 Nov; 69(11):1331-3. PubMed ID: 4092198
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
    Ratanatharathorn V, Baker LH, Balducci L, Talley RW, Hoogstraten B.
    Cancer Treat Rep; 1982 May; 66(5):1231-2. PubMed ID: 7083224
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [New cytostatics in oncological therapy].
    Osieka R, Seeber S, Bruntsch U, Gallmeier WM, Schmidt CG.
    Dtsch Med Wochenschr; 1974 Nov 29; 99(48):2468-74. PubMed ID: 4141307
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of phase I and II chemotherapeutic agents against human lymphomas heterotransplanted in nude mice.
    Sordillo PP, Helson C, Lesser M, Helson L.
    Oncology; 1983 Nov 29; 40(1):15-7. PubMed ID: 6823403
    [Abstract] [Full Text] [Related]

  • 15. Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2'-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas. Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1985 Jun 29; 69(6):713-6. PubMed ID: 3926311
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase II study of dianhydrogalactitol in malignant glioma.
    Espana P, Wiernik PH, Walker MD.
    Cancer Treat Rep; 1978 Aug 29; 62(8):1199-200. PubMed ID: 210944
    [No Abstract] [Full Text] [Related]

  • 18. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
    Haas CD, Baker L, Thigpen T.
    Cancer Treat Rep; 1981 Aug 29; 65(1-2):115-7. PubMed ID: 6261943
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase II clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study.
    Vats TS, Lui V, Trueworthy R, van Eys J.
    Cancer Treat Rep; 1981 Aug 29; 65(1-2):121-2. PubMed ID: 6939482
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.